$2.46
-0.0195-0.79%
Last update: Nov 10, 2:41 AM
Biodexa Pharmaceuticals PLC
BDRXNASDAQ
Biodexa Pharmaceuticals fell 90.8% from $26.70 to $2.46, behind the S&P 500's +10.5%. Its worst day was Dec 9 (−53.8%), and its low came Oct 13 at $0.35.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Biodexa Pharmaceuticals closed at its highest level of the year, 64.8% above where the year started.
+74.6% · S&P 500 −0.3%
EPS of $0.00 was reported on $0.00 revenue.
Story events cover the past 12 months · Times ET
−0.9% · S&P 500 −1.7%
EPS of $0.00 was reported on $0.00 revenue.
−13.8% · S&P 500 −0.4%
Biodexa Pharmaceuticals closed at its lowest level of the year, 98.7% below where the year started.
−8.6% · S&P 500 0.0%
Biodexa Pharmaceuticals shares rose 718.0%, while the S&P 500 fell 0.5%.
+718.0%, the year's best day · S&P 500 −0.5%
Where it ended: a close of $2.46 on Nov 9, 2026.
Nothing in the past 12 months.
All BDRX analyst actionsNothing in the past 12 months.
All BDRX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for BDRX and SPY from Benzinga historical bars. Not investment advice.
